20 22

BPS

BPS Board of Pharmacy Specialties 2022 Board of Pharmacy ® Annual Report Specialties ANNUAL REPORT

Table of Contents About the Board of Pharmacy Specialties®........................................................................................................... 3 2022 Board of Directors..................................................................................................................................................4 2022 BPS Staff.....................................................................................................................................................................4 A Message from the 2022 BPS Board of Directors Chair: the Value of Volunteer Leaders in the 2022 BPS Year.................................................................................................................................. 5 A Message from the BPS Executive Director........................................................................................................6 Results of the 2022 BPS Certification and Recertification Exams............................................................. 8 BPS Activities in the United States and Abroad............................................................................................... 10 2022 BPS Specialty Council on Ambulatory Care Pharmacy Report....................................................23 2022 BPS Specialty Council on Cardiology Pharmacy Report................................................................. 24 2022 BPS Specialty Council on Compounded Sterile Preparations Pharmacy Report................25 2022 BPS Specialty Council on Critical Care Pharmacy Report.............................................................. 26 2022 BPS Specialty Council on Emergency Medicine Pharmacy Report............................................27 2022 BPS Specialty Council on Geriatric Pharmacy Report.......................................................................28 2022 BPS Specialty Council on Infectious Diseases Pharmacy Report .............................................. 29 2022 BPS Specialty Council on Nuclear Pharmacy Report........................................................................30 2022 BPS Specialty Council on Nutrition Support Pharmacy Report....................................................31 2022 BPS Specialty Council on Oncology Pharmacy Report....................................................................32 2022 BPS Specialty Council on Pediatric Pharmacy Report......................................................................33 2022 BPS Specialty Council on Pharmacotherapy Report......................................................................... 34 2022 BPS Specialty Council on Psychiatric Pharmacy Report..................................................................35 2022 BPS Specialty Council on Solid Organ Transplantation Pharmacy Report............................ 36

ABOUT THE BOARD OF PHARMACY SPECIALTIES®

T

he Board of Pharmacy Specialties® (BPS) was established in 1976 and exists today as an autonomous division of the American Pharmacists Association (APhA). BPS has grown to be the premier post-licensure certification organization serving the pharmacy profession. The principal responsibilities of BPS include: • Granting recognition of appropriate pharmacy practice specialties based on criteria established by BPS • Establishing standards for certification and recertification of pharmacists in recognized pharmacy practice specialties • Granting certification and recertification to qualified pharmacists in recognized pharmacy practice specialties • Serving as a coordinating agency and information clearinghouse for organizations and pharmacists in recognized pharmacy practice specialties

The mission of BPS is to improve patient care by positioning board-certified pharmacist specialists as integral members of multidisciplinary health care teams through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. BPS Board Certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS Board Certification and recertification. BPS currently recognizes more than 57,600 active pharmacist certifications across 13 distinct specialties, including: ambulatory care pharmacy, cardiology pharmacy, compounded sterile preparations pharmacy, critical care pharmacy, geriatric pharmacy, infectious diseases pharmacy, nuclear pharmacy, nutrition support pharmacy, oncology pharmacy, pediatric pharmacy, pharmacotherapy, psychiatric pharmacy, and solid organ transplantation pharmacy, with emergency medicine pharmacy scheduled to offer the first examination in 2023. This represents a 6% increase in active certifications from 2021.

• Enhancing public/consumer protection by developing effective certification

BPS 2022 Annual Report

3

The BPS Board of Directors and BPS Staff at the April 2022 Board Meeting in Seattle, WA.

2022 BPS Board of Directors Hal E. Richards, PharmD, BCNSP

Immediate Past Chair St. Joseph’s Candler Health System Savannah, GA Pharmacist Member

Stefan R. Kowalski, BPharm, MAppSci, BCGP

University of South Australia School of Pharmacy and Medical Sciences Adelaide, SA, Australia Pharmacist Member

Ruth E. Nemire, PharmD, EdD, FCCP, FNAP, CRQM Chair-Elect Larkin University College of Pharmacy Miami, FL Pharmacist Member

Holly Divine, PharmD, BCACP, BCGP, CDCES, FAPhA

University of Kentucky College of Pharmacy Lexington, KY Pharmacist Member

Carolyn M. Clancy, MD, MACP

Veterans Health Administration Washington, DC Public Member—Nonpharmacist Health Professional

Gary C. Yee, PharmD, FCCP

University of Nebraska Medical Center Omaha, NE Pharmacist Member

Anita Siu, PharmD, BCPPS

Ernest Mario School of Pharmacy at Rutgers Piscataway, NJ Pharmacist Member

Laura Gordon

Laura Gordon Consulting, LLC Bethesda, MD Public Member

Sheila Botts, PharmD, BCPP, FCCP

Kaiser Permanente Colorado Denver, CO Pharmacist Member

Cyrine-Eliana Haidar, PharmD, BCPS, BCOP, FASHP St. Jude Children’s Research Hospital Memphis, TN Pharmacist Member

Marie E. Michnich, DrPH

National Academy of Medicine Eastsound, WA Public Member—Nonpharmacist Health Professional Ex-Officio, Non-Voting Members

Randy McDonough, PharmD, MS, BCGP, BCPS, FAPhA Towncrest, Solon Towncrest, and Towncrest Compounding Pharmacies Iowa City, IA Non-voting APhA Representative

William M. Ellis, RPh, MS, ICE-CCP

Board of Pharmacy Specialties Washington, DC Executive Director

Marianne F. Ivey, PharmD, MPH, FASHP, FFIP

Chair University of Cincinnati College of Pharmacy Seattle, WA Pharmacist Member Non-voting APhA Representative

2022 BPS Staff William M. Ellis, RPh, MS, ICE-CCP Executive Director

Kate McKenna

Communications and Engagement Specialist

Kat Peak

Examination Developer

Brian Lawson, PharmD Associate Executive Director

Alexander Jean-Baptiste, PCM Senior Manager, Content Marketing & Social Media

Jennifer Witebsky

Monica Bowler

Jacquelyn Kelly-Marshall, MBA

John Schroader, MS

Examination Developer

Senior Director, Operations, Registration, Meetings, and Logistics

Aneesh Asokan, PharmD, MBA Executive Resident

Andrew Rowland, MS

Associate Examination Developer

Avis Bullard, MS, CSSBB

Senior Director, Quality Assurance

Registrar

Senior Examination Developer

Amin Saiar, PhD

Senior Director, Psychometrics

Scott Smith Registrar

Yu Meng, PhD

Lead Psychometrician

Ellie LaNou, PharmD, BCPS

Director, Professional Affairs

Tari Brown

Certification Manager

4

BPS 2022 Annual Report

Shandee Trevino, PMP

Manager, Certification Projects and Content Development

Karen Santos

Manager, Recertification

Jessica Levy

Senior Manager, Registration

Steven P. Benson, Esq. Legal Counsel Whiteford, Taylor & Preston

Kenja Hanniford, MS

Manager, Continuing Professional Development

Ernest Wright

Senior Manager, Special Projects

Marianne F. Ivey, PharmD, MPH, FASHP, FFIP Professor Emerita University of Cincinnati College of Pharmacy Seattle, WA

A Message from the 2022

BPS Board Chair

The Value of Volunteer Leaders in the 2022 BPS Year

T

he Board of Pharmacy Specialties (BPS) had an impressive year of growth and leadership in advancing pharmacy through board certification in 2022. As the chair of the board of directors, I have been privileged to work with a dedicated, smart, and experienced board who have been thoughtful in addressing feedback from colleagues who pursue and maintain board certification. The board has enjoyed the collaboration of pharmacist leaders who are experts in each of the 14 specialties recognized by BPS serving on the specialty councils. Volunteer leaders are key to the peer-reviewed and peer-developed nature of specialty certification examinations. The number of BPS-recognized specialty areas continues to increase, with the most recent specialty in Emergency Medicine Pharmacy (BCEMP) gearing up to administer its first examination in April/May of 2023. Additional specialties are in the petition/review process including pain management pharmacy and a board-approved job analysis in pharmacoinformatics, which is the first step in recognizing a new specialty. It’s important to note that insight into new or growing pharmacy practice areas comes from our pharmacy colleagues who request BPS to review a specialty area. These requests are addressed expeditiously, continuing the pharmacist-driven nature of BPS Board Certification. Leadership from the board and specialty councils has resulted in several important changes in 2022, including an increase in the size of specialty councils to better reflect the community of pharmacists within that specialty. Stimulated by the COVID-19 pandemic, when pharmacy practitioners were needed by their patients and examination sites were limited, the board approved the continued opportunity for pharmacists to take exams through live remote proctoring (LRP) in select areas when needed. Additionally, starting in 2023, some specialty examinations will transition to continuously available testing in which eligible candidates may schedule their exam for any available session within a year rather than only during the

twice-annual examination windows. Cardiology Pharmacy, Nuclear Pharmacy, and Psychiatric Pharmacy will begin offering continuous testing in April 2023, and Oncology Pharmacy will begin in August 2023, with BPS working to transition more specialty certifications to adopt this model in the years to come. Recertification has also been improved by harmonizing all specialties to 100 recertification units over 7 years under the recertification by professional development program option. This change will apply to any new (initial or subsequent) recertification cycle year beginning in 2024 and beyond. BPS will continue recognizing recertification by examination as a recertification option in addition to continuing with a modified continuing education option as well. BPS will be one of the first pharmacy organizations to pilot a continuing professional development (CPD) framework for new recertification cycles starting in 2024, with more information coming in 2023. The BPS team and volunteer leadership have aided in the curation of this opportunity, displaying true leadership in assuring competency of board-certified pharmacy specialists. I’d like to recognize the BPS ambassadors, subject matter experts, and staff who have contributed their time and expertise this year. Their thoughtful, informative, and patient-centered service provides great examples of caring. Many of our volunteer leaders have shared perspectives from the communities they are passionate about, including mental health care, LGBTQ+ community care, and others. Finally, thank you to all of the BPS committees and councils who push the organization to represent board-certified pharmacists in the best way possible. We’ve met the goals of our strategic plan and it’s been an important year for BPS – thank you to everyone involved in making this happen! While my term as the chair of BPS was completed on December 31, 2022, I look forward to working with our 2023 chair, Ruth Nemire, and chair-elect, Cyrine Haidar, in guiding BPS in the new year. BPS 2022 Annual Report

5

William M. Ellis, RPh, MS, ICE-CCP Executive Director, Board of Pharmacy Specialties Washington, DC

A Message from the

BPS Executive Director

A

s 2022 ends and I reflect on the year, there are many things I am grateful for in addition to the many accomplishments that BPS has enjoyed.

The primary thing I am grateful for is the contribution of over one thousand volunteers who contributed their time, talent, and expertise to BPS. These volunteer leaders include the BPS Board of Directors, specialty councils, item writers, and a multitude of panelists for various activities across all specialties. Each one of these individuals contributes to the BPS mission, which is to improve patient care by promoting the recognition and value of specialized training, knowledge, and skills in pharmacy and specialty board certification of pharmacists. The tremendous efforts of our volunteers when combined with our resolute staff also led to many accomplishments in 2022. One of those accomplishments was the work to begin offering BPS certification examinations on a continuous basis starting in 2023. This sounds like a straightforward process, but there are many steps involved. In 2023, four specialties (Cardiology Pharmacy, Nuclear Pharmacy, Psychiatric Pharmacy and Oncology Pharmacy) will move to continuous testing, with the others to follow over the next few years. This change should help candidates prepare and test on a timetable that works better for them, and we look forward to the time when all specialties will be available year-round. (Please check the BPS Candidates guide for more details.) Another major accomplishment in 2022 were the plans to incorporate elements of continuing professional development (CPD) into the BPS recertification process, starting for newly certified and individuals who

6

BPS 2022 Annual Report

William Ellis, BPS Executive Director, Left, and Marianne Ivey, BPS Board Chair, Right, attended ASHP in Las Vegas in December.

recertify in 2024. This will be the first large-scale pilot of CPD in the U.S. This decision follows a number of key discussions around this topic, including a consensus conference held in June 2022 by the American Association of Colleges of Pharmacy (AACP) to bridge the gap between pharmacy education and practice. There was strong support for CPD from conference attendees, who represented most national pharmacy associations and other key stakeholders including BPS leadership and staff. In September 2022, the International Pharmaceutical Federation (FIP) lent global support to this concept, as that organization approved a statement on CPD during their global conference in Seville, Spain.

BPS also anticipates the receipt of a petition to recognize pain management pharmacy as a specialty and recently announced that it will conduct a job analysis in pharmacoinformatics to begin to explore that area as a pharmacy specialty.

The Emergency Medicine Pharmacy Specialty Council met in St. Louis for examination development activities.

BPS staff members are also active participants in the Accreditation Council for Pharmacy Education (ACPE) CPD Subcommittee to review current resources and implementation models. The CPD concept has been discussed in pharmacy for well over a decade, with conceptual framework for pharmacists’ professional development and the implications for future planning being discussed by Rouse and Maddux in 2010.1 What does this CPD pilot mean for certificants? This means that the CPD program will allow greater flexibility to self-curate learning activities based upon the pharmacist’s reflections on their own needs. This will not eliminate the assessed continuing education that is part of the current recertification process although that requirement has been reduced by approximately 20% with advent of the CPD requirement. BPS realizes that professional development takes place in multiple ways, including precepting, teaching, workplace activities and volunteerism to name just a few. This pilot will also phase in these activities for those pharmacists who have recertification dates after 2024.

In conclusion, 2022 has been a remarkably busy year; the activities listed above represent just a few of the major accomplishments. It remains an honor and a privilege to serve such a dedicated group of individuals who remain at the leading edge of patient care around the world. I am grateful for everyone who is part of the BPS process. References 1. Rouse MJ, Maddux MS. Conceptual framework for pharmacists’ professional development: implications for future planning. J Am Pharm Assoc (2003). 2010 May-Jun;50(3):343–6. doi: 10.1331/ JAPhA.2010.10024. PMID: 20452906. The Oncology Pharmacy Specialty Council met in San Diego for examination development activities.

BPS 2022 Annual Report

7

Results of the

2022 BPS Certification and Recertification Examinations

BPS Staff members attending APhA2022 in San Antonio, TX. From left to right: Jacquelyn Kelly-Marshall, MBA, Senior Director, Operations, Registration, Meetings and Logistics; Brian Lawson, PharmD, Associate Executive Director; William M. Ellis, MS, RPh, ICE-CCP, Executive Director; and Ellie LaNou, PharmD, BCPS, Director, Professional Affairs.

B

PS Specialty Certification and Recertification examinations were administered to 8,380 pharmacists throughout the United States and around the world. A total of 5,193 pharmacists passed the exams in the 13 specialties. There are now over 57,600 active BPS Certifications, which represents a 6% increase from 2021. Ambulatory Care Pharmacy: 495 of 812 candidates were certified for the first time, and 30 of 52 candidates were recertified. There are now 5,763 BPS Board-Certified Ambulatory Care Pharmacists with the designation BCACP.

8

BPS 2022 Annual Report

Cardiology Pharmacy: 115 of 220 candidates were certified for the first time. There are now 633 BPS Board-Certified Cardiology Pharmacists with the designation BCCP. Compounded Sterile Preparations Pharmacy: 253 of 360 candidates were certified for the first time. There are now 1,359 BPS Board-Certified Sterile Compounding Pharmacists with the designation BCSCP. Critical Care Pharmacy: 424 of 597 candidates were certified for the first time, and 60 of 68 were recertified. There are now 3,993 BPS Board-Certified Critical Care Pharmacists with the designation BCCCP.

Geriatric Pharmacy: 193 of 371 candidates were certified for the first time, and 8 of 17 candidates were recertified. There are now 4,640 BPS Board-Certified Geriatric Pharmacists with the designation BCGP.

Pediatric Pharmacy: 154 of 238 candidates were certified for the first time, and 8 of 11 were recertified. There are now 1,722 BPS Board-Certified Pediatric Pharmacy Specialists with the designation BCPPS.

Infectious Diseases Pharmacy: 284 of 409 candidates were certified for the first time. There are now 1,731 BPS Board-Certified Infectious Diseases Pharmacists with the designation BCIDP.

Pharmacotherapy: 2,132 of 3,583 candidates were certified for the first time, and 183 of 281 were recertified. There are now 30,505 BPS Board-Certified Pharmacotherapy Specialists with the designation BCPS.

Nuclear Pharmacy: 9 of 17 candidates were certified for the first time, and 4 of 4 candidates were recertified. There are now 364 BPS Board-Certified Nuclear Pharmacists with the designation BCNP.

Psychiatric Pharmacy: 91 of 184 candidates were certified for the first time, and 25 of 31 were recertified. There are now 1,525 BPS Board-Certified Psychiatric Pharmacists with the designation BCPP.

Nutrition Support Pharmacy: 196 of 212 candidates were certified for the first time, and 10 of 10 were recertified. There are now 1,027 Board-Certified Nutrition Support Pharmacists with the designation BCNSP.

Solid Organ Transplantation Pharmacy: 104 of 205 candidates were certified for the first time. There are now 255 BPS Board-Certified Solid Organ Transplantation Pharmacists with the designation BCTXP.

Oncology Pharmacy: 385 of 669 candidates were certified for the first time, and 30 of 39 were recertified. There are now 4,121 BPS Board-Certified Oncology Pharmacists with the designation BCOP.

Pharmacists Certified by BPS

T

he graph below illustrates the number of BPS Certifications held by pharmacists in each of the years noted in the 13 recognized areas for which testing programs have been implemented. Data includes multiple certifications.

BPS 2022 Annual Report

9

BPS Activities in the U.S. and Abroad Exploring New Pharmacy Specialties

B

PS guides the discussion, evolution, direction, and recognition of pharmacist board certification in the profession. In 2022, there were 13 recognized pharmacy specialties and over 57,600 active certifications in the U.S. and abroad. In 2023, BPS will launch the Emergency Medicine Pharmacy examination program. At the end of 2022, BPS was reviewing and evaluating 2 additional specialty areas for recognition, both of which were in various stages of development: Pain Management Pharmacy and Pharmacoinformatics. Certification program development is a formal process that starts with defining the scope and purpose of the certification program, typically through a process called job analysis (sometimes called a role delineation study or practice analysis in health care certifications). In a job analysis, the tasks performed and the competencies (i.e., the knowledge, skills, and abilities) required by professionals in the specialty practice area are identified. The competencies that are identified and validated through a job analysis comprise the examination content outline, which serves as a delineation of the certification scope and the blueprint for the examination. The job analysis process is a mixed-methods approach that consists of focus groups and validation surveys. The process starts with interviews and panel meetings with the job analysis panel, which is comprised of subject matter experts in that specialty practice area who deliberate and define the specialty practice setting, relevant competencies, tasks performed, and the linkage between the tasks and competencies. Then, a validation survey is conducted wherein a large group of subject matter experts complete a survey to validate the defined competencies. This foundational step in the exam design and development process provides a link between the specialty practice setting and the content of the assessment. The job analysis helps to ensure relevance, validity, and defensibility for a certification program. If a job analysis for a potential new specialty area yield results that suggest the area should be recognized as a

10

BPS 2022 Annual Report

specialty practice in pharmacy, BPS issues a call for a petition for a new specialty recognition. For a new specialty to be recognized by BPS, the petition must address in detail each of the criteria deemed necessary for the creation of a new specialty: need, demand, number/time, specialized knowledge, specialized functions, education and training, and transmission of knowledge. When a petition is submitted to BPS, it is made available for public review and comment. BPS reviews public comments and renders a decision on the petition. Emergency Medicine Pharmacy: In February 2020, BPS announced Emergency Medicine Pharmacy as a new pharmacy practice specialty. In December 2020, BPS announced the appointments to the Emergency Medicine Pharmacy Specialty Council. The specialty council members, led by Chair Chris Edwards, have been steadfast in constructing a new examination. In November 2022, BPS announced that the Emergency Medicine Pharmacy certification examination will be administered for the first time in 2023. Pain Management Pharmacy: After the completion of the job analysis on pain management pharmacy in 2021, the BPS Board of Directors voted to issue a call to the profession for a petition to recognize pain management pharmacy as a specialty in October 2021. Once BPS receives the petition to recognize pain management pharmacy as a BPS specialty, the board will complete its review and render a decision within 6 months. If approved, a council regarding a pain management pharmacy specialty would be established, a new job analysis would be conducted, and the process to develop the examination would begin. Pharmacoinformatics: In October 2022, the BPS Board of Directors voted to conduct a job analysis in pharmacoinformatics for 2022–2023. A call for applications will be issued for individuals actively engaged in pharmacoinformatics who are interested in being considered for appointment to the job analysis panel. The primary goal of the panel will be to draft an inventory of domains and subdomains related to the role, which will be validated via a survey administered to pharmacists practicing in the area.

Professional Development Program Request for Proposals (RFP)

I

current licensure/registration in pharmacy. Implementation of the pilot CPD recertification framework will go into effect in 2024 and apply to board-certified pharmacists certified in 2024 or beginning a new seven-year recertification cycle in 2024. The new framework will then be applied to each certification and recertification cycle

n April 2022, BPS released a request for proposal (RFP) to provide a professional development programs (PDP) for the recertification of board-certified pharmacists in each of the 14 recognized BPS specialties. The RFP outlines an update to the existing recertification pathways to include continuing professional development (CPD). This RFP concerns the assessed continuing pharmacy education (CPE) component of the PDP, not the CPD component. BPS will announce the approved professional development BPS will communicate implementation steps with all stakeholders in 2023. program providers in early 2023. Recertification, which is required every 7 years, is a process by which a board-certified pharmacist demonstrates maintenance of a defined level of contemporary knowledge and skills in the respective specialty and attests to

until it is applicable to all board-certified pharmacists by 2030. Beginning in 2024, the assessment of contemporary knowledge and skills will be accomplished through one of two recertification pathways.

International Activities

A

s of December 2022, there were 6,709 active BPS Certifications held by pharmacists in 58 countries outside of the United States. This represents an 13.4% increase over 2021 and 11.6% of the total number of active BPS Certifications in the world.

BPS 2022 Annual Report

11

• C  ouncil on Credentialing in Pharmacy (CCP) Board of Directors Meeting in January, May, and November 2022 • P  harmacy Quality Alliance (PQA) Annual Meeting in May 2022 • A  merican Associations of Colleges of Pharmacy (AACP) Bridging Pharmacy Education and Practice in June 2022 • A  merican College of Cardiology (ACC) Health Policy Think Tank in July 2022 • N  ational Pharmaceutical Association (NPhA) 2022 Annual Convention in July 2022 BPS Associate Executive Director Brian Lawson visiting the pharmacy team at Hospital Universitario La Paz in Madrid, Spain.

​ takeholder Engagement and Strategic S Partnerships

B

PS staff participated in the following profession-wide activities to monitor the landscape in the pharmacy and certification communities as well as to lead or actively participate in the discussion on initiatives that advance practice, expand specialization, and promote pharmacist board certification. • Professional Certification Coalition (PCC) monthly virtual meeting

12

BPS 2022 Annual Report

• A  ccreditation Council for Pharmacy Education (ACPE) Continuing Professional Development (CPD) Subcommittee in September 2022

The Board of Pharmacy Specialties (BPS) voted in 2022 for the elimination of the higher education transcript requirement for certification candidates in Australia, Saudi Arabia, and Singapore, allowing verification through a publicly available database which requires higher education for an active license for registration. This change will be implemented in January 2023 for pharmacist candidates who practice in Australia, Saudi Arabia, and Singapore and will align with a verification process for pharmacists in Canada and the U.S. The BPS Board Eligibility Taskforce reviewed and confirmed that databases in Australia, Canada, Saudi Arabia,

BPS Board member Stefan R. Kowalski, BPharm, M App Sci, BCGP and Brian Lawson, PharmD, staffed the BPS exhibit booth at SHPA National Conference in Brisbane, Australia.

Singapore, and the U.S. meet the standards set to verify a pharmacist’s license or registration as a component of the eligibility requirement for BPS certification. Applicants who believe their country meet the criteria may request BPS review by confirm that (1) the country requires secondary education from a university, college, school, or faculty of pharmacy as a requirement for licensure or registration; and (2) the country has a public website that verifies a pharmacist is currently licensed or registered within that jurisdiction to practice. More information on the application process can be found in the BPS Candidates Guide. Additional information for applicants outside of the U.S. and Canada can be found here. BPS Associate Executive Director Brian Lawson presented on the value of board certification during a virtual meeting of Clinical Pharmacists Association of Nigeria (CPAN) in March 2022. BPS Board Chair Mari-

anne Ivey, BPS Board member Cyrine Haidar, Oncology Pharmacy Specialty Council member Cindy O’Bryant, and Brian Lawson served as panelists for a discussion hosted by Josep M. Guiu-Segura on board certification with the Sociedad Española de Farmacia Hospitalaria (SEFH)/Consorci de Salut i Social de Catalunya in July 2022. In September 2022, Marianne Ivey and Brian Lawson attended the International Pharmaceutical Federation (FIP) Congress in Seville, Spain. Brian Lawson also met with hospital pharmacy leaders and board-certified pharmacists in Barcelona and Madrid. BPS Board member Stefan Kowalski and Brian Lawson staffed the BPS exhibit booth during Medicines Management 2022, the 46th Society of Hospital Pharmacists of Australia National Conference in Brisbane, Australia. Brian Lawson visited board-certified pharmacists and pharmacy leaders in Sydney and Melbourne.

BPS 2022 Annual Report

13

International Advisory Committee

T

he International Advisory Committee (IAC) serves in an advisory role to the BPS Board of Directors and provides a global perspective on education, training, and recognition of advanced practice and specialization in pharmacy. The IAC is charged with providing recommendations on international engagement activities and contributing insight on board certification and recertification from an international context. Additionally, the committee works to communicate the importance of board certification and recertification, as well as the value of board-certified pharmacists to stakeholders. The committee convened a virtual meeting in November 2022 to discuss progress toward 2022 strategic goals and to inform the 2023 strategic goals. The perspectives provided were part of the environmental scan process initiated by BPS. Pharmacy leaders representing Australia, Canada, Egypt, India, Lebanon, Saudi Arabia, Spain, and the United States shared information on advanced practice and board certification. The committee and invited participants included current and former BPS Board members and external advisers. IAC Members Marianne F. Ivey, PharmD, MPH, FASHP, FIP Committee Chair Chair, BPS Board of Directors Professor Emerita Division of Pharmacy Practice and Administrative Sciences College of Pharmacy University of Cincinnati Seattle, WA

Stefan R. Kowalski, BPharm, MAppSci, BCGP

BPS Board of Directors Senior Lecturer in Clinical Pharmacy and Director of Post-Graduate Clinical Pharmacy Programs University of South Australia Adelaide, South Australia

14

BPS 2022 Annual Report

Cyrine-Eliana Haidar, PharmD, BCPS, BCOP, FASHP

BPS Board of Directors Clinical Pharmacogenomics Senior Program Manager Department of Pharmacy and Pharmaceutical Sciences St. Jude Children’s Research Hospital Memphis, TN

Kristin Michaels, FAICD

Chief Executive Officer The Society of Hospital Pharmacists of Australia Canberra, Deakin, Australia Capital Territory

Bhojraj Suresh, MPharm, PhD, DSc

Pro Chancellor JSS Academy of Higher Education & Research, Mysuru, Karnataka, India

Henri R. Manasse, Jr., PhD, ScD (Hon.), FFIP Professor Emeritus Pharmacy Systems, Outcomes and Policy University of Illinois, College of Pharmacy Chicago, IL

Imad F. Btaiche, BSPharm, PharmD, BCNSP

Former Dean and Professor Lebanese American University School of Pharmacy Byblos, Lebanon

Josep Guiu-Segura, PhD, BCOP, BCPS Director of Pharmacy and Medicines Consorci de Salut i Social de Catalunya Barcelona, Spain

John A. Pieper, PharmD, FCCP, FAPhA

Former Chair, BPS Board of Directors Former President and Professor Emeritus St. Louis College of Pharmacy St. Louis, MO

Jill Martin Boone, PharmD, FASHP

Clinical Professor, Pharmacy Practice and Administrative Sciences James L Winkle College of Pharmacy University of Cincinnati Cincinnati, OH

Alan Lau, PharmD, FCCP

Professor Emeritus Director, International Clinical Pharmacy Education, Pharmacy Practice University of Illinois, College of Pharmacy Chicago, IL

Adel Sakr, PhD

Board of Trustees Chair Advisor Future University, Egypt New Cairo, Egypt

Christina Cella, BScPhm Chief Pharmacy Officer Canadian Society of Hospital Pharmacist Ottawa, Ontario

Stephen Eckel, PharmD, MHA, FAPhA, FASHP, FCCP

Associate Dean for Global Engagement Associate Professor, University of North Carolina Director of Pharmacy, Innovation Services, UNC Medical Center Chapel Hill, NC

Employer Advisory Council

T

he BPS Employer Advisory Council (EAC) advises the BPS Board and staff on strategic matters that affect, or potentially affect, employers of board-certified pharmacists. The EAC members represent different employment systems, including integrated health systems, the Department of Veterans Affairs, the Department of Defense, academic medical centers, and the U.S. Public Health Service. In 2022 the council, chaired by past BPS Board Chair Karen Gunning, continued growing the online Employer Toolkit. The toolkit is accessible on the BPS website and provides employers with resources to promote the value and impact of board certification. New additions to the Toolkit in 2022 include several infographics: “10 Ways to Recognize Pharmacists Who Achieve BPS Board Certification,” “Employer Support of Board-Certified Pharmacists in the Workplace,” and “Employers Benefit from Pharmacist Certification, Too!” Sample job descriptions for recruiting board-certified pharmacists were also added to the toolkit. A social media campaign launched in November 2022 to highlight employers and institutions that support pharmacists in pursuit of board certification. The EAC made progress on the following strategic charges during 2022: • D  evelop case studies and testimonials of pharmacists in various settings that show how certification contributes to their value as a pharmacist and pharmacy leader.

Karen M. Gunning, PharmD, BCPS, BCACP, FCCP Chair University of Utah College of Pharmacy Salt Lake City, UT

Hayley Burgess, PharmD, MBA, BCPP, CPPS VigiLanz Minneapolis, MN

Beth Chester, PharmD, MPH, BCPS, FCCP

Kaiser Permanente Washington Renton, WA

Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP, FNAP

David Hager, PharmD Visante Madison, WI

RADM (ret) Pamela Schweitzer, PharmD U.S. Public Health Service Baltimore, MD

Jeffrey J. Neigh, PharmD, MBA, MHA, MS, BCPS, LTC Laredo Specialty Hospital Laredo, TX

Hal E. Richards, PharmD, BCNSP (BPS Board Liaison)

University of Georgia College of Pharmacy Savannah, GA

University of North Texas Health Science Center College of Pharmacy Fort Worth, TX Washington State University College of Pharmacy Spokane, WA

Kevin Brooks, RPh, MBA, FACHE

M. Lynn Crismon, PharmD, BCPP, DABCP, FCCP

Health Care Service Corporation Richardson, TX

The University of Texas at Austin College of Pharmacy Austin, TX

Miami Valley Hospitals Dayton, OH

Amaka Moka, PharmD, BCPS Heather L. Ourth, PharmD, BCPS, BCGP, FASHP

Clinical Pharmacy Practice Office Washington, DC

• A  nalyze research opportunities to explore how employers quantify the value of certification.

BPS 2022 Annual Report

15

Research Committee

T

he research committee’s responsibility is to stimulate research interest, review PGY2 residency research seed grant applications, contribute to the development of research policy, and communicate to stakeholders the availability of research opportunities. The committee functions in an advisory role to the BPS Board of Directors and specialty councils to identify opportunities that will enhance the national reputation of BPS in basic and applied research. The committee prepares recommendations for the BPS Board of Directors regarding the prioritization and resource needs for future research projects. The committee includes two Board liaisons and external subject matter experts. In 2022, the Research Committee made progress on the following strategic charges: •C  onsideration of PGY2 residency research seed grant expansion • Examination of international recertification rates •A  nalysis of research opportunities to explore how employers quantify the value of certification David Price, MD, FAAFP, FACEHP, FSACME

Lars Peterson, MD, PhD

University of Colorado School of Medicine Aurora, CO

American Board of Family Medicine University of Kentucky School of Medicine Lexington, KY

Kamakshi Rao, PharmD, BCOP, FASHP

Cyrine-Eliana Haidar, PharmD, BCPS, BCOP, FASHP

UNC Medical Center UNC Eshelman School of Pharmacy Chapel Hill, NC

Gary C. Yee, PharmD, FCCP Top: The Pharmacotherapy Specialty Council met in Alexandria, VA for examination development activities. Bottom: BPS met in 2022 to give 2021 Weaver/Penna Awardee Anna Santoro, Center, her award. William Ellis, BPS Executive Director, Left, and Ruth Nemire, BPS Board Chair-Elect, Right, attended the ceremony.

16

BPS 2022 Annual Report

University of Nebraska Medical Center Omaha, NE

Robert DiDomenico, PharmD, FCCP, FHFSA, FACC

University of Illinois at Chicago College of Pharmacy Chicago, IL

St. Jude Children’s Research Hospital Memphis, TN

Andrew Dwyer, MS, PhD American Board of Pediatrics Chapel Hill, NC

Andrea Iannucci, PharmD, BCOP

UC Davis Medical Center UCSF School of Pharmacy UC Davis Medical Center School of Medicine Sacramento, CA

Brand and Marketing Taskforce

I

n 2022, the BPS Branding & Marketing Taskforce led the charge of expanding the BPS Ambassadors program. The BPS Ambassador program initially launched in 2021 with three ambassadors. In 2022, the BPS Ambassador program received 72 applications from board-certified pharmacists interested in sharing their stories and perspectives on the value of BPS certification. The task force selected five board-certified pharmacists to serve as 2022–2024 BPS ambassadors. The selected ambassadors will share their personal and professional stories about how certification has contributed to their value as a pharmacist in practice and professional advancement. Videos from the ambassadors will be featured on the BPS website and social media platforms.

As a result of a brand audit and user feedback, the BPS Brand and Marketing Taskforce has started preliminary efforts to redesign and restructure the BPS website. In August 2022, the task force issued a RFP seeking vendors to enhance the functionality of the BPS website by making it more mobile responsive and user-friendly. The website redesign is planned for 2023. Laura Gordon 

Laura Gordon Consulting, LLC  Bethesda, MD

Holly Divine, PharmD, BCACP, BCGP, CDCES, FAPhA  University of Kentucky  Lexington, KY

Stefan R. Kowalski, BPharm, MAppSci, BCGP 

University of South Australia School of Pharmacy and Medical Sciences  Adelaide, SA, Australia

The task force and BPS staff successfully launched the BPS Newly Certified Pharmacist Toolkit and the Board-Certified Pharmacist’s Welcome Packet. These resources offer newly certified pharmacists information and resources to promote and maintain their new BPS credentials. Newly certified pharmacists will be equipped with social media graphics to celebrate their new achievement in addition to background information that will support them in sharing information about BPS Certification, such as how to promote your credential, and historical information about BPS. In March 2022, BPS relaunched its podcast series, The BPS Board-Certified Pharmacist Podcast. With this relaunch, BPS has increased its distribution of the podcast across multiple podcast streaming platforms to increase availability for listeners to access the new podcast episodes. The BPS Board-Certified Pharmacist Podcast can be found on podcast streaming platforms such as Spotify, Apple Music, and Google Podcasts.

The 2022–2024 BPS ambassadors, from left to right: Guari Godbole, BCGP; Linda Gutierrez, BCACP, BCPS; Jamalee Huntley, BCPPS; Grace John, BCIDP; and Stephen Small, BCCCP, BCPPS, BCPS.

BPS 2022 Annual Report

17

Warren E. Weaver/Richard P. Penna Award

which is adjacent to the institute on the same campus.

PS announced that Baptist Health’s Miami Cancer Institute Pharmacy Program in Miami, FL, was named the 2022 recipient of the Warren E. Weaver/Richard P. Penna Award in the organization category. The 2022 individual category award goes to James Ponto, MS, RPh, BCNP, FASHP, FAPhA.

The oncology pharmacy team is proud to have 32 board-certified pharmacists, 10 of whom dual-certified. Fully integrated into the care of the cancer patient, the pharmacists educate patients on oral oncolytic medications; perform rounds with multidisciplinary teams; and are active leaders within disease management teams, research committees, and a system-wide Pharmacy and

B

BPS announced the establishment of the Warren E. Weaver/Richard P. Penna Award as part of the BPS 40th anniversary celebration. The award recipient must be an individual or patient care organization who has advanced health quality and/or patient care by promoting the recognition and value of specialized training, knowledge, and skills in pharmacy and the BPS Board Certification of pharmacists. Nominations for the Weaver/Penna Award were solicited separately for patient care organizations and individual persons, and an award is provided to one recipient in each category at the discretion of the BPS Board of Directors. “This year’s awardees truly reflect the purpose and intent of the Weaver/Penna Award: to recognize those going above and beyond to provide patient care and further the pharmacy profession through certification. James Ponto and the Miami Cancer Institute Pharmacy Program personify the commitment to learning, service, and pharmacy that is at the heart of the mission of the Board of Pharmacy Specialties,” said 2022 Chair-Elect Ruth E. Nemire, PharmD, EdD. Patient Care Organization Category Award The Miami Cancer Institute is a destination cancer center approaching its 5th year in southern Florida. The institute provides high-quality cancer care and access to clinical trials for patients in the tri-county area in which it is located. Miami Cancer Institute sees about 1,200 patient visits daily and provides care to cancer patients seven days a week, including holidays. The institute serves patients through both the infusion center and the dedicated oncology, hematology, and transplant inpatient units at Baptist Hospital Miami,

18

BPS 2022 Annual Report

2022 BPS Board of Directors Chair-elect, Ruth Nemire (third from left), presenting the 2022 Weaver/Penna Award to Miami Cancer Institute Pharmaceutical Department.

Therapeutics committee. The oncology pharmacists are medication experts, with weekly pharmacy lectures and monthly multidisciplinary education for advanced practice providers and nurses. In addition to the clinical services that the board-certified pharmacists provide, the Operations Team has several staff who are BPS Board-Certified Sterile Compounding Pharmacists (BCSCP); one of these now leads the Compounding Quality Assurance Program for the entire health care system. The team has standardized the policies and procedures for cleanrooms, optimized competency for the pharmacist and technician staff, and most recently, participated in an experiential learning site for technician students within the health system to address the staff shortage.

Another achievement includes Miami Cancer Institute’s pharmacy technicians advancing their knowledge and professional growth through additional certifications from the Pharmacy Technician Certification Board (PTCB). The Oncology Pharmacy team has achieved 2 PTCB-certified technicians within the past year. The Miami Cancer Institute pharmacy team is internally motivated to be the best for the patients they serve. Additionally, the team is motivated to be active within professional organizations at the local, state, and national levels. The pharmacy team has participated in over 50 presentations and 20 publications and research posters. Staff have also held numerous leadership positions in pharmacy and cancer organizations over the past 3 years. “We are thrilled to receive the Weaver/Penna Award in recognition of the Miami Cancer Institute pharmacy team’s diligent commitment to the profession and our patients,” said Madeline Camejo, Chief Pharmacy Officer of Baptist Health. “Our pharmacy team has a wealth of experience [which is] critical to the day-today activities. Additionally, the team has the drive to maintain a certification that encourages the long-term development of evidence-based practices.” The presentation of the BPS Weaver/Penna Award to Miami Cancer Institute Pharmaceutical Department took place in May 2022 at their facility in Miami, FL. Individual Category Award The recipient of the Weaver/Penna Award in the individual category is James Ponto, MS, RPh, BCNP, FASHP, FAPhA, Emeritus Clinical Professor at the University of Iowa College of Pharmacy. “Over the past several decades, I’ve seen the tremendous growth of board certification and I’m proud of the role that I played in the expansion of BPS specialties and the overall number of board-certified pharmacists. I am humbled and honored to receive this award in recognition of my dedication to pharmacist development and advancement of the profession as a whole,” said Ponto.

2022 BPS Board of Directors Chair Marianne Ivey, Left, and BPS Executive Director Bill Ellis, Right, presented James Ponto, Center, with the 2022 Weaver/Penna Award.

Ponto has maintained an outstanding career with a commitment to building the foundation for and promoting the value of pharmacist board certification. Ponto was one of 63 pharmacists who passed the first BPS exam in Nuclear Pharmacy in 1982, the first BPS specialty certification offered. Ponto subsequently recertified every 7 years and is among a handful of colleagues who have continuously maintained their board certification since the inception of the first BPS specialty. Ponto was also an engaged member of the Nuclear Pharmacy Specialty Council after becoming board-certified, serving 2 terms: 1982–1985 and 1986–1989. During his time as chair of the Nuclear Pharmacy Specialty Council, Ponto led many discussions with the specialty council and the BPS Board of Directors regarding the duration of board certification and ultimately supported 7-year time-limited certification rather than enduring certification. In his role as chair, Ponto developed the pathways for recertification (i.e., successfully passing the recertification examination or completing necessary continued professional development requirements). Ponto was engaged in petitions for specialty recognition of Nutrition Support Pharmacy and Pharmacotherapy through his role as chair of the Nuclear Pharmacy Specialty Council.

BPS 2022 Annual Report

19

Ponto was further engaged with the inaugural Nutrition Support Specialty Council as a nonspecialist for 1989–1992 and 1992–1995 terms immediately following completion of his term on the Nuclear Pharmacy Specialty Council. He assisted in developing eligibility criteria, policies, procedures, and he worked to establish and implement the first Nutrition Support certification exam. Ponto continued to participate in the growth of the recognized BPS specialties through his time on the BPS Board of Directors. From 2013 to 2018, he led the evaluation and approval of six new specialty areas. During his two terms, his service included proposing the concept for the Weaver/Penna Award as a part of the recognition of the 40th anniversary of BPS.

pharmacist board certification. As the community of board-certified pharmacists grows, it is important to pursue qualitative and quantitative research topics to fully explore the process of pharmacy specialization and the diverse practice settings and patient populations with whom pharmacists engage,” said BPS Board Chair Marianne F. Ivey, PharmD, MPH, FASHP, FFIP. BPS is proud to recognize these researchers and support completion of their work.

The presentation of the BPS Weaver/Penna Award to James Ponto took place in San Antonio, TX at the APhA Annual Meeting & Exposition in March 2022. BPS offers congratulations to these deserving recipients of the Warren E. Weaver/Richard P. Penna Awards for 2022.

PGY2 Pharmacy Residency Research Grant Recipients

B

PS is proud to announce the recipients of the fifth annual Post-Graduate Year 2 (PGY2) Pharmacy Residency Research Seed Grants as Amanda Charlton, PharmD, and Timothy Jones, PharmD. This program offers up to two $5,000 seed grants to PGY2 pharmacy residents who design projects that evaluate the impact of pharmacist board certification on medication-related outcomes for patients, demonstrate the value of board certification for pharmacist specialists to key stakeholder groups (i.e., patients, payers, physicians, and other health care providers), or contribute to credentialing or privileging of pharmacist specialists across practice settings. The grant will go toward the completion of their research projects. “We look forward to seeing the findings of the two research teams and what insights they acquire about

20

BPS 2022 Annual Report

Amanda Charlton, PharmD, PGY2 pharmacotherapy resident at Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, was recognized for her proposal, “Distribution and Accessibility of Board-Certified Pharmacists.” Charlton will conduct research in collaboration with Krystal K. Haase, PharmD, BCPS, BCCCP, FCCP; Eric J. MacLaughlin, PharmD, BCPS, FASHP, FCCP; and Jeremy H. Johnson, PharmD.  The proposal submitted by Charlton stated the following: Board-certified pharmacists (BCPs) are uniquely qualified to improve medication-related outcomes for patients through advanced practice roles. Despite pharmacists being coined as the “most readily

accessible health care provider,” a pilot study by our group suggests that BCPs are not routinely accessible to patients who reside outside of large metropolitan areas. We found that in Texas, 98% of BCPs practice in urban areas, with 70% of counties having no certified pharmacists. However, it is unknown whether similar patterns of disparity exist in other states. All-cause mortality rates are higher for patients who reside in rural areas of the United States, and lack of access to health care providers is one of three major explanatory factors for this difference. Characterizing the geographic representation of BCPs on a national scale would be of value in determining the degree to which they are accessible to all patients. Furthermore, comparing states based on degree of accessibility may identify determinants beyond geographies, such as health care policy, provider legislation, and compensation that drive board certification, particularly outside of metropolitan areas. Identifying drivers and barriers is critical to focusing future policy, advocacy, and credentialing efforts for pharmacists. Our long-term goal is to ensure that all patients have access to comprehensive medication management services provided by appropriately credentialed pharmacists. The objective of this application is to characterize the current accessibility of BCP and to determine factors that drive accessibility patterns at the state level. We hypothesize that accessibility patterns vary by state and are associated with specific geographical, policy, practice, educational, and legislative characteristics. Our rationale is that identification and characterization of patterns, particularly for highly successful states, will help better inform future efforts in legislation, advocacy, training, and credentialing. Timothy Jones, PharmD, PGY2 critical care pharmacy resident at Augusta University Medical Center, was selected for his proposal, “Impact of Board Certification on Quality of Care Provided by Evening Critical Care Pharmacist Services.” Jones will conduct research in collaboration with Andrea Sikora, PharmD,

MSCR, BCCCP, FCCM; Kelli Keats, PharmD, BCCCP; Aaron Chase, PharmD; and Christy Forehand, PharmD, BCCCP, FCCM. The proposal submitted by Jones stated the following: Critical care pharmacists are considered essential members of the health care team; however, justification of new positions, especially in the evening or weekend shifts, remains a significant challenge. Workload of intensive care unit (ICU) clinicians has come to the forefront as a concern due its relationship with poor quality of patient care and clinician burnout. Lack of clinical pharmacist positions in non-daytime, non-weekday shifts is a critical gap. The purpose of this project is to investigate how board certification in critical care affects the number and intensity of interventions provided during evening shift services. The central hypothesis is that board certification increases both the number and intensity of interventions that can be provided by the clinical pharmacist. This hypothesis will be tested through 2 specific aims: (1) evaluate the quantity and intensity of documented interventions performed by a board certified critical care pharmacist (BCCCP) and non–board-certified second-shift pharmacists

BPS 2022 Annual Report

21

at an academic medical center and (2) determine the effect of a BCCCP-credentialed pharmacist on patient safety and clinical decision-making assistance in non-daytime shift services. Interventions are tracked through an electronic health record system as part of routine standard-of-care. Demonstrating increased value of board certification for evening shift services has significant potential to improve justification efforts for clinical pharmacist position in non-daytime, non-weekday shifts. “BPS is pleased to recognize Dr. Charlton and Dr. Jones for their research efforts, which support the growing body of literature surrounding pharmacist board certification. We were fortunate to receive many quality proposals for funding and thank the other teams who submitted proposals,”  said BPS Director of Professional Affairs Ellie LaNou, PharmD, BCPS.   More information about previous awardees and the PGY2 Pharmacy Residency Research Seed Grants program can be found at www.bpsweb.org/bps-seedgrant. BPS Recognized for Certification Excellence In January 2022, the National Commission for Certifying Agencies (NCCA) awarded three specialty certifications under BPS for compliance to the NCCA Standards for the Accreditation of Certification Programs: Cardiology Pharmacy (BCCP), Infectious Diseases Pharmacy (BCIDP), and Compounded Sterile Preparations Pharmacy (BCSCP). NCCA also reaccredited the Geriatric Pharmacy specialty certification (BCGP). BPS now holds NCCA accreditation for 12 specialty certification programs. More information about NCCA and ISO-IEC

22

BPS 2022 Annual Report

170124 Accreditation can be found at www.bpsweb. org/about-bps/accreditation. In June 2022, the Department of Defense (DOD) reconized BPS as a credentialing opportunity for service members; BPS is now included on the Credentialing Opportunities On-Line (COOL) website. 13 out of 14 BPS credentials met the DOD credentialing standards required for inclusion on COOL. (Emergency Medicine Pharmacy is not listed because testing will not begin until 2023.) Each military service branch has their own service-specific COOL programs designed to match military occupations to civilian credentials. The DOD COOL webpage is a portal for the individual military COOL programs, as each branch of service disseminates the information on their own COOL websites and offers variations on the information for their specific branches. Review The Soldiers Guide to Certification infographic for more details. In August 2022, the United States Nuclear Regulatory Commission (NRC) granted the Board-Certified Nuclear Pharmacist (BCNP) specialty with continued recognition as the credential satisfies requirements for authorized nuclear pharmacists under NRC Regulations Title 10, Code of Federal Regulations (CFR) 35.55. The requirements under this statute affirm a professional standard of education, training, and professional experience. The NRC regularly re-evaluates which programs meet their rigorous standards. More information on the NRC can be found at www.nrc.gov/reading-rm/doc-collections/cfr/part035/part035-0055.html.

2022 BPS Specialty Council on

Ambulatory Care Pharmacy Report

I

n 2022, the BPS Specialty Council on Ambulatory Care Pharmacy participated in exam assembly and publication as well as exam item review. A cohort of 40 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. The council convened in-person in March 2022 for an examination development meeting, and it conducted its virtual business meeting in July 2022. The council reviewed the performance of the professional development programs for the recertification of Board-Certified Ambulatory Care Pharmacists (BCACP) and provided recommendations for quality improvement to the approved providers: a joint program of the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists and a program of the American Pharmacists Association. The council re-elected Christie Schumacher as the 2023 chair and Lauren Pamulapati as the 2023 vice chair. The council also moved Katie Cardone and Lauren Pamulapati for reappointment and Brandon Sucher

and Jessica Merrey for appointment for 3-year terms beginning in 2023. 2022 BPS Ambulatory Care Pharmacy Examination Results Spring: 229 of 393 were certified for the first time in Ambulatory Care Pharmacy, and 11 of 19 were recertified by examination. Fall: 266 of 419 candidates were certified for the first time in Ambulatory Care Pharmacy, and 19 of 33 were recertified by examination. 2022 BPS Ambulatory Care Pharmacy Recertification by Continuing Education Results 280 certificants maintained their BCACP by earning 100 continuing education hours over 7 years by December 2022. As of December 2022, there were 5,763 BPS Board-Certified Ambulatory Care Pharmacists with the designation BCACP.

2022 BPS Specialty Council on Ambulatory Care Pharmacy Council Chair Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP

Hillary Duvivier, PharmD, BCPS, BCACP, NCPS

Immigration and Customs Enforcement Health Service Corps Miami, FL

Midwestern University Chicago College of Pharmacy Chicago, IL

McKenzie C. Ferguson, PharmD, BCPS

Council Vice Chair Lauren G. Pamulapati, PharmD, BCACP

Clark Kebodeaux, PharmD, BCACP

Virginia Commonwealth University School of Pharmacy Richmond, VA

Council Members Joshua Bayer, PharmD, BCPS, AAHIVP

Department of Veterans Affairs River Valley Outpatient Clinic/Wausau CBOC Tomah, WI

Katie Cardone, PharmD, BCACP, FNKF, FASN, FCCP Albany College of Pharmacy and Health Sciences Albany, NY

Southern Illinois University Edwardsville School of Pharmacy Edwardsville, IL University of Kentucky College of Pharmacy Lexington, KY

Josh Guffey, PharmD, BCACP, BCPS, BC-ADM

Carolinas HealthCare System Center for Advanced Practice UNC Eshelman School of Pharmacy Charlotte, NC

Jennifer Rosselli, PharmD, BCPS, BCACP, BC-ADM, CDCES Southern Illinois University Edwardsville School of Pharmacy Edwardsville, IL

Council Chair Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Midwestern University Chicago College of Pharmacy Chicago, IL BPS 2022 Annual Report

23

2022 BPS Specialty Council on

Cardiology Pharmacy Report

I

n 2022, the BPS Specialty Council on Cardiology Pharmacy participated in exam assembly and publication as well as exam item review. A cohort of 16 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. A cohort of 13 standard setting judges was recruited to participate in a standard setting study, which is the determination of a passing standard to be applied to the examination. The council convened in-person in October 2022 for an examination development meeting, and it conducted its virtual business meeting in July 2022. The council reviewed the performance of the professional development programs for the recertification of Board-Certified Cardiology Pharmacists (BCCP) and provided recommendations for quality improvement to the approved provider: a joint program of the American College of Clinical Pharmacy and the American Society

of Health-System Pharmacists. The council elected Craig J. Beavers as the 2023 chair and Caitlin Gibson as the 2023 vice chair. The council also moved Caitlin Gibson for reappointment and moved Azita H. Talasaz and Joel Marrs for appointment for 3-year terms beginning in 2023. 2022 BPS Cardiology Pharmacy Examination Results Spring: 59 of 107 were certified for the first time in Cardiology Pharmacy. Fall: 56 of 103 candidates were certified for the first time in Cardiology Pharmacy. As of December 2022, there were 633 BPS Board-Certified Cardiology Pharmacists with the designation BCCP.

2022 BPS Specialty Council on Cardiology Pharmacy Council Chair Kristen Pogue, PharmD, BCCP, BCPS-AQ Cardiology, FCCP Michigan Medicine/University of Michigan College of Pharmacy Ann Arbor, MI

Council Vice Chair Craig J. Beavers, PharmD, BCCP, BCPS-AQ Cardiology, AACC, CACP, FAHA, FACC, FCCP University of Kentucky Healthcare Lexington, KY

Council Members Candice L. Garwood, PharmD, BCPS, BCACP, FCCP

Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences Detroit, MI

Rhynn Soderstrom, PharmD, BCPS, BCCP Children’s Hospital Colorado Denver, CO

Council Chair Kristen Pogue, PharmD, BCCP, BCPS-AQ Cardiology, FCCP Michigan Medicine/University of Michigan College of Pharmacy Ann Arbor, MI 24

BPS 2022 Annual Report

Carla Knowles, PharmD, BCACP, BCCP Kaiser Permanente Georgia Atlanta, GA

Ilya Danelich, PharmD, BCPS, BCCP AstraZeneca Pharmaceuticals Wilmington, DE

Leo F. Buckley, PharmD, BCPS, BCCP Brigham and Women’s Hospital Boston, MA

Terrance O’Shea, PharmD, BCGP Omnicare Englewood, OH

Caitlin Gibson, PharmD, MEd, BCPS, BCCP

Virginia Commonwealth University School of Pharmacy Richmond, VA

2022 BPS Specialty Council on

Compounded Sterile Preparations Pharmacy Report

I

n 2022, the BPS Specialty Council on Compounded Sterile Preparations Pharmacy participated in exam assembly and publication as well as exam item review. A cohort of 50 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. The council convened in-person in October 2022 and conducted its virtual business meeting in July 2022. The council reviewed the performance of the professional development programs for the recertification of Board-Certified Sterile Compounding Pharmacists (BCSCP) and provided recommendations for quality improvement to the approved providers: the American Pharmacists Association and the American Society of Health-System Pharmacists.

The council reelected Barbara A. Knightly as the 2023 chair and elected Kathleen Kane as the 2023 vice chair. The council moved Jon Hicks, David Melton, Nicholas Baker, and Kenneth “Chip” Lazenby for appointment for 3-year terms beginning in 2023. 2022 BPS Compounded Sterile Preparations Pharmacy Examination Results Spring: 136 of 198 candidates were certified for the first time in Compounded Sterile Preparations Pharmacy. Fall: 117 of 162 candidates were certified for the first time in Compounded Sterile Preparations Pharmacy. As of December 2022, there were 1,358 BPS Board-Certified Sterile Compounding Pharmacists with the designation BCSCP.

2022 BPS Specialty Council on Compounded Sterile Preparations Pharmacy Council Chair Barbara A. Knightly, PharmD, RPh InfuCare RX West Chester, PA

Vice Chair Binh Nguyen, PharmD, MSRegSci, BCSCP Food and Drug Administration Huntington Beach, CA

Council Members Corbin Bennett, PharmD, MPH Kaiser Permanente Fresno, CA

Mike Carroll, BSPharm, RPh, BCSCP Option Care Health New Orleans, LA

Kathleen J. Kane, PharmD, BCSCP, DPLA University of Chicago Chicago, IL

Dana Albers, PharmD, BCSCP

Novant Health Presbyterian Medical Center Charlotte, NC

James Finney, PharmD, BCPS, BCSCP UF Health The Villages Hospital The Villages, FL

Jessica Hawkins, PharmD, BCSCP, BCPS Lexington VA Health Care System Lexington, KY

Sarrah Hein, PharmD, BCPPS Akron Children’s Hospital Boardman, OH

Council Chair Barbara A. Knightly, PharmD, RPh InfuCare RX West Chester, PA BPS 2022 Annual Report

25

2022 BPS Specialty Council on

Critical Care Pharmacy Report

I

n 2022, the BPS Specialty Council on Critical Care Pharmacy participated in exam assembly and publication, exam item review, and reclassification of the item bank to the new examination content outline. A cohort of 25 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. A cohort of 16 job analysis panelists was recruited to participate in the job analysis, which yielded a new examination content outline. The council convened in-person in September 2022 for an examination development meeting and conducted its virtual business meeting in June 2022. The council reviewed the performance of the professional development programs for the recertification of Board-Certified Critical Care Pharmacists (BCCCP) and provided recommendations for quality improvement to the approved providers: the American College of Clinical Pharmacy, the American Society of Health-System Pharmacists, and the Society of Critical Care Medicine. The council elected Carrie Griffiths as the 2023 chair and Russel Roberts as the 2023 vice chair. The council also

moved Carrie Griffiths and Russell Roberts for reappointment and Jeremiah Duby and Abdalla Ammar for appointment for three-year terms beginning in 2023. 2022 BPS Critical Care Pharmacy Examination Results Spring: 206 of 297 were certified for the first time in Critical Care Pharmacy, and 14 of 18 were recertified by examination. Fall: 218 of 300 candidates were certified for the first time in Critical Care Pharmacy, and 46 of 50 were recertified by examination. 2022 BPS Critical Care Pharmacy Recertification by Continuing Education Results 371 certificants maintained their BCCCP by earning 100 continuing education hours over 7 years by December 2022. As of December 2022, there were 3,994 BPS Board-Certified Critical Care Pharmacists with the designation BCCCP.

2022 BPS Specialty Council on Critical Care Pharmacy Council Chair Jennifer Cole, PharmD, BCPS, BCCCP, FCCP, FCCM Veterans Healthcare System of the Ozarks Fayetteville, AR

Council Vice Chair Carrie Griffiths, PharmD, BCCCP, FCCM Wingate University School of Pharmacy Wingate, NC

Sarah Miller, PharmD, MS, BCNSP

University of Montana Skaggs School of Pharmacy Missoula, MT

Paul O’Donnell, PharmD, BCCCP, BCPS

Midwestern University Chicago College of Pharmacy Chicago, IL

Russel Roberts, PharmD, BCCCP, FCCM Massachusetts General Hospital Boston, MA

Council Members Christy Forehand, PharmD, BCCCP, FCCM

Todd Walroth, PharmD, BCPS, BCCCP

Thaddaus Hellwig, PharmD, BCPS, FASHP

Debbie Zock, PharmD, MBA, MHA, BCPS, BCCCP, BCIDP

Augusta University Medical Center Augusta, GA

South Dakota State University College of Pharmacy Brookings, SD

Council Chair Jennifer Cole, PharmD, BCPS, BCCCP, FCCP, FCCM Veterans Healthcare System of the Ozarks Fayetteville, AR 26

BPS 2022 Annual Report

Eskenazi Health Indianapolis, IN

Aventura Hospital and Medical Center Aventura, FL

2022 BPS Specialty Council on

Emergency Medicine Pharmacy Report

I

n 2022, the BPS Specialty Council on Emergency Medicine Pharmacy participated in exam assembly and publication as well as exam item review. A cohort of 25 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. The council convened in-person in March 2022 and October 2022 for examination development

meetings and conducted its virtual business meeting in June 2022. The first examinations will be administered in 2023. Christopher Edwards and Michael Thomas will continue to serve as chair and vice chair, respectively, for 2023.

2022 BPS Specialty Council on Emergency Medicine Pharmacy Council Chair Christopher Edwards, PharmD, BCPS, FASHP University of Arizona College of Pharmacy Marana, AZ

Council Vice Chair Michael Thomas, PharmD, BCPS, FCCP

Samford University McWhorter School of Pharmacy Birmingham, AL

Council Members Patrick Bridgeman, PharmD, MPHc, BCPS Bristol Meyer Squibb Lawrenceville, NJ

Nicole Harger, PharmD, BCPS, BCCCP University of Cincinnati Medical Center Cincinnati, OH

Brian Potoski, PharmD, BCPS-AQ ID University of Pittsburgh School of Pharmacy Pittsburgh, PA

Jennifer Mando-Vandrick, PharmD, BCPS Duke University Hospital Durham, NC

Alison (Katie) Hiles, PharmD, BCPS OrthoIndy Hospital Indianapolis, IN

Ryan Waybright, PharmD, BCCCP

Avera McKennan Hospital & University Health Center Sioux Falls, SD

Stacy Voils, PharmD, MS, FCCM, FCCP Syneos Health/Janssen Pharmaceuticals Ponte Vedra, FL

Council Chair Christopher Edwards, PharmD, BCPS, FASHP University of Arizona College of Pharmacy Marana, AZ BPS 2022 Annual Report

27

2022 BPS Specialty Council on

Geriatric Pharmacy Report

I

n 2022, the BPS Specialty Council on Geriatric Pharmacy participated in exam assembly and publication, exam item review, and reclassification of the item bank to the new examination content outline. A cohort of 16 job analysis panelists was recruited to participate in the job analysis, which yielded a new examination content outline. The council convened in-person in November 2022 for an examination development meeting and conducted its virtual business meeting in July 2022. The council reviewed the performance of the professional development programs for the recertification of Board-Certified Geriatric Pharmacists (BCGP) and provided recommendations for quality improvement to the approved providers: a program of the American Society of Consultant Pharmacists and a joint program of the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists. The council elected Christopher Alderman as the 2023 chair and Dennis Williams as the 2023 vice chair. The council also moved Emalee Collins, Paige Mathew, Mimi

Lo, and Teisha Robertson for appointment for 3-year terms beginning in 2023. 2022 BPS Geriatric Pharmacy Examination Results Spring: 92 of 179 were certified for the first time in Geriatric Pharmacy, and 6 of 11 were recertified by examination. Fall: 101 of 192 candidates were certified for the first time in Geriatric Pharmacy, and 2 of 6 were recertified by examination. 2022 BPS Geriatric Pharmacy Recertification by Continuing Education Results 53 certificants maintained their BCGP by earning 100 continuing education hours over 7 years by December 2022. As of December 2022, there were 4,640 BPS Board-Certified Geriatric Pharmacists with the designation BCGP.

2022 BPS Specialty Council on Geriatric Pharmacy Council Chair Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP, FNAP University of North Texas System College of Pharmacy Fort Worth, TX Washington State University College of Pharmacy Spokane, WA

Council Vice Chair Christopher P. Alderman, BPharm, PhD, Dip Proj Manage, BCPP, BCGP, FSHP, FASCP University of South Australia Adelaide, SA, Australia

Council Members Tara Bruneski, BPharm, PharmD, BCPS, BCGP Alberta Health Services Calgary, Alberta, Canada

Jessica B. Emshoff, BS, PharmD, RPh, BCPS, BCGP Northeast Ohio Medical University College of Pharmacy Rootstown, OH

Jessica W. Merrey, PharmD, MBA, BCPS, BCACP, BCGP The Johns Hopkins Hospital Baltimore, MD

Donna Lisi, PharmD, BCPS, BCGP, BCACP, BCPP, BCMTMS Somerset, NJ

Dennis Williams, PharmD, BCPS, AE-C, FCCP, FAPhA, FASHP

University of North Carolina Eshelman School of Pharmacy Chapel Hill, NC

Luigi Brunetti, PharmD, MPH, BCPS, BCGP Ernest Mario School of Pharmacy Rutgers Piscataway, NJ

Creaque Charles, PharmD, BCGP

Texas Southern University College of Pharmacy and Health Sciences Friendswood, TX

Council Chair Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP, FNAP University of North Texas System College of Pharmacy, Fort Worth, TX Washington State University College of Pharmacy, Spokane, WA 28

BPS 2022 Annual Report

2022 BPS Specialty Council on

Infectious Diseases Pharmacy Report

I

n 2022, the BPS Specialty Council on Infectious Diseases Pharmacy participated in exam assembly and publication as well as exam item review. A cohort of 18 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. The council elected not to conduct an exam development meeting in-person for 2022 and conducted its business meeting virtually in July 2022. The council reviewed the performance of the professional development programs for the certification of the Board-Certified Infectious Diseases Pharmacists (BCIDP) and provided recommendations for quality improvement to the approved providers: a joint program of the American Society of Health-System Pharmacists and the American College of Clinical Pharmacy and a program of the Society of Infectious Diseases Pharmacists (SIDP).

The council reelected Jennifer E. Girotto as the 2023 chair and elected Conan MacDougall as the 2023 vice chair. The council moved Curtis Collins, Steve Mok, and Radhika Polisetty for reappointment and Wesley Kufel and Kirthana Beaulac for appointment for 3-year terms beginning in 2023. 2022 BPS Infectious Diseases Pharmacy Examination Results Spring: 144 of 216 candidates were certified for the first time in Infectious Diseases Pharmacy. Fall: 140 of 193 were certified for the first time in Infectious Diseases Pharmacy. As of December 2022, there were 1,731 BPS Board-Certified Infectious Diseases Pharmacists with the designation BCIDP.

2022 BPS Specialty Council on Infectious Diseases Pharmacy Council Chair Jennifer E. Girotto, PharmD, BCPPS, BCIDP University of Connecticut Storrs, CT

Council Vice Chair Curtis Collins, PharmD, MS, BCPS-AQ ID, BCIDP, FASHP St. Joseph Mercy Health System Ann Arbor, MI

Council Members Melissa E. Badowski, PharmD, MPH, BCPS, BCIDP, AAHIVP, FIDSA, FCCP University of Illinois at Chicago College of Pharmacy Chicago, IL

Sean Cosgriff, PharmD, BCOP, FOSHP VA Portland Health Care System Portland, OR

Conan MacDougall, PharmD, MAS, BCPS, BCIDP University of California San Francisco San Francisco, CA

Kathryn G. Merkel, PharmD, BCPS, BCPPS, BCIDP St. David’s South Austin Medical CenterAustin, TX

Steve Mok, PharmD, MBA, BCPS, BCIDP Wolters Kluwer, Health Atlanta, GA

Radhika S. Polisetty, PharmD, BCIDP, BCPS-AQ ID, AAHIVP

Midwestern University Chicago College of Pharmacy Chicago, IL

Fiona Doukas, BPharm, MPH, FSHPA

Australian Commission on Safety and Quality in Health Care Sydney, NSW, Australia

Council Chair Jennifer E. Girotto, PharmD, BCPPS, BCIDP University of Connecticut Storrs, CT BPS 2022 Annual Report

29

2022 BPS Specialty Council on

Nuclear Pharmacy Report

I

n 2022, the BPS Specialty Council on Nuclear Pharmacy participated in exam assembly and publication as well as exam item review. A cohort of 9 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. The council convened in-person in March 2022 and conducted its business meeting virtually in July 2022. The council reviewed the performance of the professional development programs for the certification of the Board-Certified Nuclear Pharmacists (BCNP) and provided recommendations for quality improvement to the approved provider, Purdue University College of Pharmacy. The council elected Melissa Foster as 2023 chair and Leana Gebo as 2023 vice chair. The council moved Ronald Crowe, Eric Smith, Jeff Clanton, and Nic Mastascusa

for appointment for 3-year terms beginning in 2023. 2022 BPS Nuclear Pharmacy Examination Results Spring: 6 of 11 candidates were certified for the first time, and 2 of 2 were recertified by examination. Fall: 3 of 6 candidates were certified for the first time, and 2 of 2 were recertified by examination. 2022 BPS Nuclear Pharmacy Recertification by Continuing Education Results 43 certificants maintained their BCNP by earning 100 continuing education hours by December 2022. As of December 2022, there were 364 BPS Board-Certified Nuclear Pharmacists with the designation BCNP.

2022 BPS Specialty Council on Nuclear Pharmacy Council Chair Garcia Simon-Clarke, PharmD, MS, BCNP, CCP Atlantic Health System—Morristown Medical Center Morristown, NJ

Council Vice Chair Melissa Foster, PharmD, BCNP

Cardinal Health Nuclear & Precision Health Solutions Chattanooga, TN

Council Members GT Dolan, PharmD, MS, BCNP

Blue Ridge Isotopes/Precision Nuclear of Virginia Salem, VA

Leana Gebo, PharmD, BCNP

Cardinal Health Nuclear & Precision Health Solutions Beltsville, MD

Kenneth T. Cheng, BS Pharm, PhD, BCNP National Institutes of Health Clinical Center Bethesda, MD

Council Chair Garcia Simon-Clarke, PharmD, MS, BCNP, CCP Atlantic Health System—Morristown Medical Center Morristown, NJ 30

BPS 2022 Annual Report

Shunsuke Toyoda, PharmD, BCPS, BCNSP, BCSCP, CPHQ PIH Health Hospital-Whittier Los Angeles, CA

Paul Knapp, RPh, MBA, BCNP

Cardinal Health Nuclear & Precision Health Solutions Dublin, OH

Charles E. Leonard, PharmD, MSCE, FISPE

University of Pennsylvania Perelman School of Medicine Philadelphia, PA

Steve Mattmuller, MS, RPh, BCNP Kettering Medical Center Kettering, OH

2022 BPS Specialty Council on

Nutrition Support Pharmacy Report

I

n 2022, the BPS Specialty Council on Nutrition Support Pharmacy participated in exam assembly and publication as well as exam item review. A cohort of 11 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. The council convened in-person in September 2022 for an examination development meeting and conducted its business meeting virtually in July 2022. The council reviewed the performance of the professional development programs for the certification of the Board-Certified Nutrition Support Pharmacists (BCNSP) and provided recommendations for quality improvement to the approved provider, Purdue University College of Pharmacy. The council reelected Angela Bingham as the 2023 chair and Todd Canada as the 2023 vice chair. The council moved Todd Canada for reappointment, and Beth Deen and Vivian Zhao for appointment for 3-year

terms beginning in 2023. 2022 BPS Nutrition Support Pharmacy Examination Results Spring: 84 of 91 candidates were certified for the first time, and 7 of 7 were recertified by examination. Fall: 112 of 121 candidates were certified for the first time, and 3 of 3 were recertified by examination. 2022 BPS Nutrition Support Pharmacy Recertification by Continuing Education Results 27 certificants maintained their BCNSP by earning 100 continuing education hours over 7 years by December 2022. As of December 2022, there were 1,028 BPS Board-Certified Nutrition Support Pharmacists with the designation BCNSP.

2022 BPS Specialty Council on Nutrition Support Pharmacy Council Chair Angela L. Bingham, PharmD, BCPS, BCNSP, BCCCP, FASPEN, FASHP, FCCP University of the Sciences Philadelphia College of Pharmacy Philadelphia, PA

Council Vice Chair Todd W. Canada, PharmD, BCNSP, BCCCP, FASHP, FTSHP, FASPEN University of Texas MD Anderson Cancer Center Houston, TX

Council Members Taylor Barnes, PharmD, BCPPS

Winnie Palmer Hospital for Women and Babies Orlando, FL

Johanna D. Bezjak, PharmD, BCNSP CarePathRx Pittsburgh, PA

Sara Bliss, PharmD, BCPS, BCNSP, BCCCP Duke University Hospital Durham, NC

Katayoon “Kathy” Ghomeshi, PharmD, MBA, BCPS, CPPS University of California San Francisco Medical Center San Francisco, CA

Karrie Derenski, PharmD, BCNSP, BCCCP, CNSC, FASPEN CoxHealth Springfield, MO

Ronald Dickerson, PharmD, BCNSP

University of Tennessee Health Science Center Memphis, TN

Carol J. Rollins, PharmD, MS, BCNSP, FASHP, FASPEN University of Arizona College of Pharmacy Phoenix, AZ

Council Chair Angela L. Bingham, PharmD, BCPS, BCNSP, BCCCP, FASPEN, FASHP, FCCP University of the Sciences Philadelphia College of Pharmacy Philadelphia, PA BPS 2022 Annual Report

31

2022 BPS Specialty Council on

Oncology Pharmacy Report

I

n 2022, the BPS Specialty Council on Oncology Pharmacy participated in exam assembly and publication, exam item review, and reclassification of the item bank to the new examination content outline. A cohort of 9 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. A cohort of 22 job analysis panelists was recruited to participate in the job analysis, which yielded a new examination content outline. The council convened in-person in October 2022 for an examination development meeting and conducted its business meeting virtually in July 2022. The council reviewed the performance of the professional development programs for the certification of the Board-Certified Oncology Pharmacists (BCOP) and provided recommendations for quality improvement to the approved providers: a joint program of the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists and a program of the Hematology/Oncology Pharmacy Association.

The council elected Thu Oanh T. Dang as the 2023 chair and Janelle Perkins as the 2023 vice chair. The council moved Thu Oanh T. Dang and Erik DeFreitas for reappointment, and Alexandre Chan and Yun Man for appointment for 3-year terms beginning in 2023. 2022 BPS Oncology Pharmacy Examination Results Spring: 192 of 332 candidates were certified for the first time, and 15 of 19 were recertified by examination. Fall: 193 of 337 candidates were certified for the first time, and 15 of 20 were recertified by examination. 2022 BPS Oncology Pharmacy Recertification by Continuing Education Results 284 certificants maintained their BCOP by earning 100 continuing education hours over 7 years by December 2022. As of December 2022, there were 4,121 BPS Board-Certified Oncology Pharmacists with the designation BCOP.

2022 BPS Specialty Council on Oncology Pharmacy Council Chair Deborah A. Ward, PharmD, BCPS, BCOP St. Jude Children’s Research Hospital Memphis, TN

Council Vice Chair Thu Oanh T. Dang, PharmD, BCOP Massachusetts General Hospital Boston, MA

Council Members Mimi Lo, PharmD, BCPS, BCOP

University of California San Francisco Medical Center San Francisco, CA

Rabia S. Atayee, PharmD, BCPS, APh

University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences San Diego, CA

Council Chair Deborah A. Ward, PharmD, BCPS, BCOP St. Jude Children’s Research Hospital Memphis, TN 32

BPS 2022 Annual Report

LTC Erik DeFreitas, PharmD, MA, MPH, BCOP Dwight D. Eisenhower Army Medical Center Fort Gordon, GA

Jin Han, PharmD, PhD, BCPS

University of Illinois at Chicago College of Pharmacy Chicago, IL

Cindy L. O’Bryant, PharmD, BCOP, FCCP, FHOPA University of Colorado Skaggs School Pharmacy and Pharmaceutical Sciences Aurora, CO

Janelle B. Perkins, PharmD, BCOP

University of South Florida College of Pharmacy Tampa, FL

Joseph Bubalo, PharmD, BCPS, BCOP Oregon Health & Science University Portland, OR

2022 BPS Specialty Council on

Pediatric Pharmacy Report

I

n 2022, the BPS Specialty Council on Pediatric Pharmacy participated in exam assembly and publication, exam item review, and reclassification of the item bank to the new examination content outline. A cohort of 17 job analysis panelists was recruited to participate in the job analysis, which yielded a new examination content outline. The council convened in-person in October 2022 for an examination development meeting and conducted its business meeting virtually in July 2022. The council reviewed the performance of the professional development programs for the certification of the Board-Certified Pediatric Pharmacy Specialists (BCPPS) and provided recommendations for quality improvement to the approved providers: the American College of Clinical Pharmacy, the American Society of Health-System Pharmacists, and the Pediatric Pharmacy Association.

Nichols, Mary Subramanain, and Susan Villegas for appointment for 3-year terms beginning in 2023.

The council elected Elizabeth Beckman as the 2023 chair and elected John “Brock” Harris as the 2023 vice chair. The council moved Monica Bogenschutz, Kristen

As of December 2022, there were 1,722 BPS Board-Certified Pediatric Pharmacy Specialists with the designation BCPPS.

2022 BPS Pediatric Pharmacy Examination Results Spring: 78 of 123 were certified for the first time in Pediatric Pharmacy, and 4 of 5 were recertified by examination. Fall: 76 of 115 candidates were certified for the first time in Pediatric Pharmacy, and 4 of 6 were recertified by examination. 2022 BPS Pediatric Pharmacy Recertification by Continuing Education Results 245 certificants maintained their BCPPS by earning 100 continuing education hours over 7 years by December 2022.

2022 BPS Specialty Council on Pediatric Pharmacy Council Chair Beth Deen, PharmD, BCNSP, BCPPS Cook Children’s Medical Center Fort Worth, TX

Council Vice Chair Elizabeth Beckman, PharmD, BCPS, BCPPS, BCCCP Kentucky Children’s Hospital at UK HealthCare Lexington, KY

Council Members Kelly Bobo, PharmD, MBA, BCPS, BCPPS Le Bonheur Children’s Hospital Memphis, TN

Sabrina Boehme, PharmD, MBA, BCPS, BCPPS Intermountain Primary Children’s Hospital Salt Lake City, UT

Michael Gaby, PharmD, JD, BCPS, FCCP

University of Illinois at Chicago College of Pharmacy Chicago, IL

John “Brock” Harris, PharmD, BCPS, BCPPS, FCCP Wingate University School of Pharmacy Wingate, NC

Jamalee Huntley, PharmD, BCPPS Arkansas Children’s Northwest Springdale, AR

Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP WellDyneRx Lakeland, FL

Marla C. Tanski, PharmD, MPH, BCPPS The Johns Hopkins All Children’s Hospital St. Petersburg, FL

Council Chair Beth Deen, PharmD, BCNSP, BCPPS Cook Children’s Medical Center Fort Worth, TX BPS 2022 Annual Report

33

2022 BPS Specialty Council on

Pharmacotherapy Report

I

n 2022, the BPS Specialty Council on Pharmacotherapy participated in exam assembly and publication as well as exam item review. A cohort of 11 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. A cohort of 19 item review panelists were recruited to assist with the Specialty Council by performing supplementary review of exam items. The council convened in-person in September 2022 for an examination development meeting and conducted its business meeting virtually in June 2022. The council reviewed the performance of the professional development programs for the certification of the Board-Certified Pharmacotherapy Specialists (BCPS) and provided recommendations for quality improvement to the approved providers: the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists.

pointment and Breanne Piazik, Erik Maki, Helen Moon, and Mary Mekheil for appointment for 3-year terms beginning in 2023.

The council re-elected Felix Yam as the 2023 chair and Jacqueline Olin as the 2023 vice chair. The council moved Heather Nyman and Jacqueline Olin for reap-

As of December 2022, there were 30,505 BPS Board-Certified Pharmacotherapy Specialists with the designation BCPS.

2022 BPS Pharmacotherapy Examination Results Spring: 985 of 1,776 were certified for the first time in Pharmacotherapy, and 52 of 93 were recertified by examination. Fall: 1,147 of 1,807 candidates were certified for the first time in Pharmacotherapy, and 131 of 188 were recertified by examination. 2022 BPS Pharmacotherapy Recertification by Continuing Education Results 2,134 certificants maintained their BCPS by earning 120 continuing education hours over 7 years by December 2022.

2022 BPS Specialty Council on Pharmacotherapy Council Chair Felix K. Yam, PharmD, MAS, BCPS-AQ Cardiology Apple, Inc. San Diego, CA

Council Vice Chair Jacqueline L. Olin, PharmD, MS, BCPS, CPP, CDCES, FASHP, FCCP Clinical Education Alliance Monroe, NC

Council Members Lindsay M. Arnold, PharmD, MPH, BCPS St. Elizabeth’s Medical Center Brighton, MA

Shawn Griffin, PharmD, BCOP

University of California Irvine School of Pharmacy and Pharmaceutical Sciences Irvine, CA

Council Chair Felix K. Yam, PharmD, MAS, BCPS-AQ Cardiology Apple, Inc. San Diego, CA 34

BPS 2022 Annual Report

Sheri Herner, PharmD, MHSA, BCPS, CPPS, FCCP Kaiser Permanente Colorado Aurora, CO

Bruce M. Jones, PharmD, BCPS, FIDSA St Joseph’s/Candler Health System Savannah, GA

Courtney Eatmon, PharmD, BCPP Veterans Affairs Medical Center Lexington, KY

Heather Nyman, PharmD, BCPS University of Utah College of Pharmacy Salt Lake City, UT

Nicole T. Reardon, PharmD, BCPS, FCCM HCA Florida North Florida Hospital Gainesville, FL

2022 BPS Specialty Council on

Psychiatric Pharmacy Report

I

n 2022, the BPS Specialty Council on Psychiatric Pharmacy participated in exam assembly and publication, exam item review, and reclassification of the item bank to the new examination content outline. A cohort of 35 item writers was recruited and was provided training on item-writing principles and how to submit draft examination items. A cohort of 8 standard setting judges was recruited to participate in a standard setting study, which is the determination of a passing standard to be applied to the examination. The council convened in-person in September 2022 for an examination development meeting and conducted its business meeting virtually in June 2022. The council reviewed the performance of the professional development programs for the certification of the Board-Certified Psychiatric Pharmacists (BCPP) and provided recommendations for quality improvement to the approved provider, the American Association of Psychiatric Pharmacists, who was previously known as the College of Psychiatric and Neurologic Pharmacists. The council reelected Kelly Gable as the 2023 chair and

Emma Palmer as the 2023 vice chair. The council moved Emma Palmer and Anna Santoro for reappointment, and Lindsey Binns, Richard J. Silvia, and Farah Khorassani for appointment for 3-year terms beginning in 2023. 2022 BPS Psychiatric Pharmacy Examination Results Spring: 40 of 85 candidates were certified for the first time in Psychiatric Pharmacy, and 8 of 10 were recertified by examination. Fall: 51 of 99 candidates were certified for the first time in Psychiatric Pharmacy, and 17 of 21 were recertified by examination. 2022 BPS Psychiatric Pharmacy Recertification by Continuing Education Results 98 certificants maintained their BCPP by earning 100 continuing education hours over 7 years by December 2022. As of December 2022, there were 1,525 BPS Board- Certified Psychiatric Pharmacists with the designation BCPP.

2022 BPS Specialty Council on Psychiatric Pharmacy Council Chair Kelly Gable, PharmD, BCPP

Southern Illinois University Edwardsville School of Pharmacy Edwardsville, IL

Council Vice Chair Emma Palmer, PharmD, BCPS, BCPP

University of Cincinnati James L. Winkle College of Pharmacy Cincinnati, OH

Calvin Daniels, PharmD, PhD, BCPPS, DPLA St. Jude Children’s Research Hospital Memphis, TN

Amber R. Douglass, PharmD, BCPS, BCPP Department of Veterans Affairs (Connecticut) Bluffton, SC

Sheryl Thedford, PharmD, PhD, BCPS, BCPP University of Maryland School of Pharmacy Baltimore, MD

Council Members Elayne D. Ansara, PharmD, BCPS, BCPP

Marketa Marvanova, PharmD, PhD, BCPP, BCGP, FASCP

Veteran Health Indiana Indianapolis, IN

Pacific University School of Pharmacy Hillsboro, OR

Michelle Chu, PharmD, BCACP, APh

CDR Anna Santoro, PharmD, MA, BCGP, BCPP, NCPS

University of Southern California School of Pharmacy Los Angeles, CA

Federal Bureau of Prisons Federal Medical Center Devens Ayer, MA

Council Chair Kelly Gable, PharmD, BCPP Southern Illinois University Edwardsville School of Pharmacy Edwardsville, IL BPS 2022 Annual Report

35

2022 BPS Specialty Council on

Solid Organ Transplantation Pharmacy Report

I

n 2022, the BPS Specialty Council on Solid Organ Transplantation Pharmacy participated in exam assembly and publication, exam item review, exam item writing, and reclassification of the item bank to the new examination content outline. A cohort of 14 panelists were recruited to participate in the job analysis, which yielded a new examination content outline. The council convened in-person in June 2022 for an examination development meeting and conducted its business meeting virtually in July 2022. Members continue succession planning for transitioning inaugural council members off of the specialty council in order to transition newly board-certified solid organ transplantation pharmacists onto the council.

The council moved to elect Emily Benefield as the 2023 chair and Mary Leick as the 2023 vice chair. BPS Solid Organ Transplantation Pharmacy Examination Results Spring: 66 of 116 candidates were certified for the first time in Solid Organ Transplantation Pharmacy. Fall: 38 of 89 candidates were certified for the first time in Solid Organ Transplantation Pharmacy. As of December 2022, there were 255 BPS BoardCertified Transplant Pharmacists with the designation BCTXP.

2022 BPS Specialty Council on Solid Organ Pharmacy Transplantation Council Chair Matt Harris, PharmD, MHS, BCPS Duke University Hospital Durham, NC

Council Vice Chair Emily Benefield, PharmD, BCPS, BCPPS Seattle Children’s Hospital Seattle, WA

Council Members Barrett Crowther, PharmD, BCPS, FCCP, FAST University of Colorado Health Aurora, CO

Stephanie Anders, PharmD, BCPS Ochsner Clinic Foundation New Orleans, LA

Council Chair Matt Harris, PharmD, MHS, BCPS Duke University Hospital Durham, NC 36

BPS 2022 Annual Report

Christina Doligalski, PharmD, BCPS, CPP, FAST, FCCP University of North Carolina at Chapel Hill Chapel Hill, NC

Linda J. Fitzgerald, PharmD, BCPS, BCTXP Michigan Medicine Ann Arbor, MI

Heather J. Johnson, PharmD, BCPS University of Pittsburgh School of Pharmacy Pittsburgh, PA

Mary Leick, PharmD, BCPS, BCTXP Nebraska Medicine Omaha, NE

Demetra Tsapepas, PharmD, BCPS, FAST New York-Presbyterian Hospital New York, NY

For more information, visit www.BPSweb.org

20974